The table below shows AGIOS PHARMACEUTICALS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$54.03M
$36.50M
$26.82M
$14.24M
$0.00
$0.00
Cost of revenue
$6.34M
$4.17M
$2.88M
$1.70M
$0.00
$0.00
Gross profit
-
-
-
-
-
-
R&D
$339.54M
$301.29M
$295.53M
$279.91M
$256.97M
$220.81M
SG&A
AGIO annual revenue (10-K history)
AGIOS PHARMACEUTICALS, INC. reported annual revenue of $54.03M for fiscal year 2025. That is up 48.0% from $36.50M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $69.89M (FY 2016) to $54.03M. Figures come from the company's audited annual reports as filed with the SEC.
